| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.6B | $3.6B | $3.5B | $2.9B | $0.7B | $0.5B | $0.5B |
| Cost of Revenue | — | — | — | $2.0B | $1.6B | $1.3B | $1.1B | $1.1B |
| Gross Profit | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $0.3B | $0.2B | $0.2B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.5B | $0.4B | $0.4B | $0.3B | $0.3B |
| Operating Income | $0.5B | $0.5B | $-1.6B | $0.6B | $0.7B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.3B | $0.2B | $-1.8B | $0.3B | $0.6B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $4.39 | $2.82 | $-27.54 | $5.57 | $9.95 | $2.10 | $0.78 | $1.33 |
| EPS (Diluted) | $4.37 | $2.81 | $-27.54 | $5.56 | $9.90 | $2.08 | $0.77 | $1.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B | $8.6B | $9.1B | $11.5B | $4.5B | $3.9B | $3.4B | $2.6B |
| Current Assets | $2.5B | $2.5B | $2.7B | $2.8B | $2.1B | $1.8B | $1.4B | $1.5B |
| Cash & Equivalents | $0.4B | $0.4B | $0.5B | — | — | $0.5B | — | — |
| Total Liabilities | $6.1B | $6.3B | $6.6B | $7.0B | $1.7B | $1.5B | $1.4B | $0.7B |
| Current Liabilities | $0.9B | $0.8B | $0.8B | $1.0B | $0.5B | $0.4B | $0.3B | $0.3B |
| Stockholders' Equity | $2.7B | $2.3B | $2.5B | $4.5B | $2.9B | $2.4B | $2.0B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.3B | $0.5B | $0.6B | $0.5B | $0.2B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-4.6B | $-0.2B | $-0.2B | $-0.9B | $0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.6B | $-0.5B | $-0.3B | $4.0B | $-0.1B | $-0.1B | $0.5B | $-0.2B |